Nellie Gillies Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 509 State St, Augusta, KS 67010 Phone: 316-775-2289 |
Mallory Paradis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 509 State St, Augusta, KS 67010 Phone: 316-775-2289 Fax: 316-775-2280 |
Cole Michael Kitterman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1510 Ohio St, Augusta, KS 67010 Phone: 316-775-5456 Fax: 316-775-4108 |
Dr. Brett M Kappelmann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 509 State St, Augusta, KS 67010 Phone: 316-775-2289 Fax: 316-775-2280 |
Mr. Tony R Folsom, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Ames St, Baldwin City, KS 66006 Phone: 785-594-0340 Fax: 785-594-0343 |
Laura M Hibberts, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 E 1330th Rd, Baldwin City, KS 66006 Phone: 785-594-3284 |
Dr. Andrea Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Ames St, Baldwin City, KS 66006 Phone: 785-594-0340 |
Sara Strand Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Ames St, Baldwin City, KS 66006 Phone: 785-594-0340 |
Holly Gripka, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15415 Pinehurst Dr, Basehor, KS 66007 Phone: 913-724-3666 Fax: 913-724-3667 |
Mary Elaine Reilly Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15415 Pinehurst Dr, Basehor, KS 66007 Phone: 913-724-3666 |
Kelly Barnes Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 Military Ave, Baxter Springs, KS 66713 Phone: 620-856-3030 |
Carissa Christie, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 Military Ave, Baxter Springs, KS 66713 Phone: 620-856-5858 Fax: 620-856-3976 |
Mrs. Catherine Lee Smith, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2970 Military Ave, Baxter Springs, KS 66713 Phone: 620-856-5140 Fax: 620-856-5121 |
Dr. Tosha Bowen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1902 Nickel Rd, Belleville, KS 66935 Phone: 785-955-0173 |
Stephanie A Schintler Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2420 G St, Belleville, KS 66935 Phone: 785-527-2254 |
Dr. Jared Collette, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 23rd St, Belleville, KS 66935 Phone: 785-955-0537 |
Kevin L Couture, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1806 M St, Belleville, KS 66935 Phone: 785-527-2146 Fax: 785-527-5528 |
Mr. J Robert Arbuthnot, PHARMACIST, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1806 M St, Belleville, KS 66935 Phone: 785-526-2146 Fax: 785-527-5528 |
Katie Diane Mispagel Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 S Mill St, Beloit, KS 67420 Phone: 785-738-2285 Fax: 785-738-5144 |
Christopher Mondero, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 S Mill St, Beloit, KS 67420 Phone: 785-738-2285 |
News Archive
According to U.S. researchers smoking increases the risk that men who develop prostate cancer will die from their disease. The longer the men smoked, the greater the risk, said Stacey Kenfield of the Harvard School of Public Health in Boston, whose study appears in the Journal of the American Medical Association. Prostate cancer is the second-leading cause of cancer death in men behind lung cancer
The New York Times reports that President Barack Obama will unveil a broad new research initiative Tuesday, starting with $100 million next year, to find ways to record and map human brain circuits.
The life-threatening condition depicts the fact that the body does not have enough energy to function. Scientists at the University of Cambridge say mutations in the AKT2 gene are to blame. Writing in the journal Science, they say there are already cancer drugs which target a similar process.
Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.
› Verified 3 days ago